Call for Cardiovascular Innovations

Click HERE to submit your CRT 2019 Cardiovascular Innovations

Deadline: Cardiovascular Innovations ideas must be submitted electronically by January 10, 2019.

Do you have the next innovative cardiovascular technology? We are actively searching for the latest inventions, innovations, and therapies to be presented and discussed in the CRT 2019 Cardiovascular Innovations sessions.

The interactive format of these sessions offers selected presenters the ability to introduce their technology to a panel of expert physicians that can comment on the innovation design, features, and potential benefits for both the patient and physician.

CRT 2019 invites you to submit information on new and innovative:


  • Selected submissions of innovative technologies will be invited to orally present their technology during CRT 2019, and the presenters will be Faculty. As a member of the Faculty, your CRT 2019 registration fee will be discounted to $295*.
  • Cardiovascular Innovations sessions include, but are not limited to: DES, BRS & DCB Technologies, Valve & Structural. The top 10 presenters will also qualify for the Best Innovation Award to be given at a special symposium at CRT.

Submission Details:

  • Submissions are open to all companies with innovative products/services that have not yet been fully market-released. Technology status may include early stage/prototype, pre-clinicals, FIM, CE Mark, or other. Clinical data are not required.
  • All Cardiovascular Innovations must be submitted electronically as a PowerPoint presentation. Please be sure to include the name of the product, its application, and a suggested presenter.

Deadline: Cardiovascular Innovations ideas must be submitted electronically by December 15, 2018.

Inquires: If you have any questions, please contact

*If you submit in this category but do not receive approval, CRT will offer you a discounted registration rate of $400. Directions will be provided at time of review notification.

The CRT cardiovascular innovation award offers inventors and startups in the field of cardiology the opportunity to obtain exposure to their technology among the lead medical community, regulatory officers, industry, and investors with the potential to advance their technology forward and to bring it to clinical use.
The finalists will have the opportunity to meet the experts face-to-face, and have to prove the merit of their idea – and in the process receive valuable advice and guidance – an opportunity that money really cannot buy.

– Ron Waksman, MD